DRS. EVERS - VANDERSCHOOT
ActiveSummary
DRS. EVERS - VANDERSCHOOT has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €281,753. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 87% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 16-05-2007 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.302.353.792 3570 Alken, since 16-05-2007
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Board and ownership
Board
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €470,997
- ▲ 2.9%
- Turnover
- ≈ €730,000
- estimated
- Profit
- €281,753
- ▼ 16.2%
- Equity
- €1.1m
- ▼ 0.9%
- Total assets
- €1.2m
- ▼ 3.3%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 11.85, cash €431,238Size: total assets €1.2mFigures for financial year 2025 (filed on 27-07-2026)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
100=
equity 92.3% of total assets
Liquidity
95+7
short-term debt 7.6% · cash 36.3%
Profitability
98-2
return on assets 23.7%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 11.85 (8.96 in 2024), above the usual 1.5. Short-term debt is 7.6% and cash 36.3% of total assets. 7.7% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 83% on liquidity, 59% on profitability and 34% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
4 days early
2024
1 day early
2023
33 days early
2022
30 days late
2021
20 days early
2020
9 days early
2019
18 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 8 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 27-07-2026 at the NBB all 18 filings
Turnover
€597,262▼ 25.9%
2018 · €806,546
EBIT margin
51.6%▼ 2.2pp
2018 · 53.9%
Net result
€281,753▼ 16.2%
2024 · €336,136
Working capital
€982,778▲ 2.6%
2024 · €957,747
Multi-year overview
2018 to 2025, 8 financial yearsTurnover
no figure
2025
20182025
Operating result
€418,222
▲ 2.6%
2025
20182025
Net result
€281,753
▼ 16.2%
2025
highest quarter of the sector
20182025
EBIT margin
no figure
2025
20182025
Equity
€1.1m
▼ 0.9%
2025
highest quarter of the sector
20182025
Total assets
€1.2m
▼ 3.3%
2025
highest quarter of the sector
20182025
Debt
€90,994
▼ 24.7%
2025
20182025
Working capital
€982,778
▲ 2.6%
2025
highest quarter of the sector
20182025
Solvency
92.3%
▲ 2.2pp
2025
highest quarter of the sector
20182025
Current ratio
11.85
▲ 2.89
2025
highest quarter of the sector
20182025
Return on assets (ROA)
23.7%
▼ 3.7pp
2025
middle half of the sector
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Turnover€0.8m-€0.6m
Operating result€0.4m-€0.1m▼ 69.6%€0.08m▼ 42.3%€0.3m▲ 271%€0.3m▲ 9.1%€0.4m▲ 16.0%€0.4m▲ 13.9%€0.4m▲ 2.6%
Net result€0.3m-€0.07m▼ 72.8%€0.03mwithin the sector's middle half▼ 52.6%€0.2mabove the sector's middle half▲ 423%€0.2mabove the sector's middle half▲ 15.0%€0.2mabove the sector's middle half▲ 18.1%€0.3mabove the sector's middle half▲ 37.9%€0.3mabove the sector's middle half▼ 16.2%
EBIT margin53.9%-51.6%
Equity€0.6m-€0.6m▲ 13.2%€0.5mabove the sector's middle half▼ 16.4%€0.6mabove the sector's middle half▲ 22.1%€0.8mabove the sector's middle half▲ 32.4%€1.0mabove the sector's middle half▲ 23.3%€1.1mabove the sector's middle half▲ 6.4%€1.1mabove the sector's middle half▼ 0.9%
Total assets€0.9m-€0.8m▼ 5.7%€0.7mabove the sector's middle half▼ 15.4%€0.9mabove the sector's middle half▲ 25.6%€1.0mabove the sector's middle half▲ 8.9%€1.2mabove the sector's middle half▲ 18.9%€1.2mabove the sector's middle half▲ 6.2%€1.2mabove the sector's middle half▼ 3.3%
Debt€0.3m-€0.2m▼ 36.0%€0.2m▼ 12.0%€0.3m▲ 35.1%€0.1m▼ 49.6%€0.1m▼ 10.4%€0.1m▲ 4.1%€0.09m▼ 24.7%
Working capital€0.4m-€0.5m▲ 26.6%€0.4mabove the sector's middle half▼ 16.4%€0.5mabove the sector's middle half▲ 31.7%€0.8mabove the sector's middle half▲ 43.0%€0.9mabove the sector's middle half▲ 13.3%€1.0mabove the sector's middle half▲ 11.9%€1.0mabove the sector's middle half▲ 2.6%
Solvency61.8%-74.1%▲ 12.3pp73.3%within the sector's middle half▼ 0.8pp71.3%within the sector's middle half▼ 2.0pp86.7%above the sector's middle half▲ 15.4pp90.0%above the sector's middle half▲ 3.3pp90.2%above the sector's middle half▲ 0.2pp92.3%above the sector's middle half▲ 2.2pp
Current ratio3.58-7.04▲ 3.454.63within the sector's middle half▼ 2.403.26within the sector's middle half▼ 1.376.84above the sector's middle half▲ 3.588.38above the sector's middle half▲ 1.548.96above the sector's middle half▲ 0.5811.85above the sector's middle half▲ 2.89
Return on assets (ROA)29.9%-8.6%▼ 21.3pp4.8%below the sector's middle half▼ 3.8pp20.1%within the sector's middle half▲ 15.3pp21.2%within the sector's middle half▲ 1.1pp21.1%within the sector's middle half▼ 0.1pp27.4%within the sector's middle half▲ 6.3pp23.7%within the sector's middle half▼ 3.7pp
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 3% higher than in 2024 and the highest since 2021. It is the fourth rise in a row.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.2m
Fixed assets
€113,496 ▼ 23.8%
Current assets
€1.1m ▼ 0.4%
Equity and liabilities €1.2m
Equity
€1.1m ▼ 0.9%
Debt
€90,994 ▼ 24.7%
Debt's share of the balance-sheet total falls from 9.8% to 7.7%. Equity and debt are lower.
Key figures and ratios
EBITDA
€467,509▲
2024 · €454,114
Cash flow
€331,040▼
2024 · €382,502
Debt to equity
0.08▼
2024 · 0.11
ROE
25.7%▼
2024 · 30.4%
Interest coverage
over 100▲
2024 · -1761.29
Debt ≤ 1 year
€90,574▼
2024 · €120,380
Income taxes
€161,559▼
2024 · €161,996
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | €1,455 | €8,739 | €129,730 | €14,526 | €13,914 |
| Depreciation and write-downs of the year | €70,145 | €52,456 | €31,662 | €46,366 | €49,287 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Turnover70 | €806,546 | - | - | - | €597,262 | - | - | - | - |
| Non-recurring operating income76A | - | - | - | - | - | €5,951 | €13,457 | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | - | - | €283,008 | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €86,246 | €86,485 | €86,241 | €70,145 | €52,456 | €31,662 | €46,366 | €49,287 | ▲ 6.3% |
| Other operating charges640/8 | - | - | - | €3,995 | €3,432 | €3,896 | €3,501 | €3,488 | ▼ 0.4% |
| Gross operating margin9900 | €524,617 | €222,635 | €166,681 | €356,809 | €364,288 | €393,423 | €457,615 | €470,997 | ▲ 2.9% |
| Operating profit (loss)9901 | €434,506 | €132,135 | €76,243 | €282,669 | €308,400 | €357,866 | €407,748 | €418,222 | ▲ 2.6% |
| Financial income75/76B | - | - | - | €31 | €572 | €7,119 | €90,127 | €25,271 | ▼ 72.0% |
| Recurring financial income75 | €111 | - | €443 | €31 | €572 | €7,119 | €90,127 | €25,271 | ▼ 72.0% |
| Financial charges65/66B | - | - | - | €5,580 | €2,743 | €773 | -€258 | €181 | - |
| Recurring financial charges65 | €13,600 | €11,114 | €8,342 | €5,580 | €2,743 | €773 | -€258 | €181 | - |
| Profit (loss) for the period before taxes9903 | €421,017 | €121,021 | €68,344 | €277,120 | €306,228 | €364,211 | €498,132 | €443,312 | ▼ 11.0% |
| Income taxes67/77 | €156,205 | €50,070 | €35,493 | €97,609 | €99,845 | €120,452 | €161,996 | €161,559 | ▼ 0.3% |
| Profit (loss) for the period9904 | €266,307 | €72,447 | €34,346 | €179,511 | €206,384 | €243,759 | €336,136 | €281,753 | ▼ 16.2% |
| Profit (loss) for the period to be appropriated9905 | €269,212 | €75,351 | €37,251 | €179,511 | €206,384 | €243,759 | €336,136 | €281,753 | ▼ 16.2% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.9m | €0.8m | €0.7m | €0.9m | €1.0m | €1.2m | €1.2m | €1.2m | ▼ 3.3% |
| Fixed assets21/28 | €0.4m | €0.3m | €0.2m | €0.1m | €0.09m | €0.2m | €0.1m | €0.1m | ▼ 23.8% |
| Tangible fixed assets22/27 | €0.4m | €0.3m | €0.2m | €0.1m | €0.09m | €0.2m | €0.1m | €0.1m | ▼ 23.8% |
| Land and buildings22 | - | - | - | €0.1m | €0.07m | €0.06m | €0.04m | €0.02m | ▼ 42.9% |
| Plant, machinery and equipment23 | - | - | - | - | €0.001m | €0.001m | €0.004m | €0.02m | ▲ 276% |
| Furniture and vehicles24 | - | - | - | €0.006m | €0.004m | €0.1m | €0.1m | €0.07m | ▼ 27.9% |
| Assets under construction and advance payments27 | - | - | - | - | €0.008m | - | - | - | - |
| Current assets29/58 | €0.5m | €0.6m | €0.5m | €0.8m | €0.9m | €1.0m | €1.1m | €1.1m | ▼ 0.4% |
| Amounts receivable after more than one year29 | - | - | - | - | €0.03m | €0.2m | €0.2m | €0.07m | ▼ 63.3% |
| Other amounts receivable291 | - | - | - | - | €0.03m | €0.2m | €0.2m | €0.07m | ▼ 63.3% |
| Amounts receivable within one year40/41 | €0.2m | €0.2m | €0.1m | €0.2m | €0.2m | €0.3m | €0.2m | €0.2m | ▼ 0.8% |
| Trade receivables40 | - | - | - | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | ▼ 0.8% |
| Other amounts receivable41 | - | - | - | €0.02m | €0.04m | €0.1m | - | - | - |
| Current investments50/53 | - | €0.04m | €0.08m | €0.1m | €0.2m | €0.2m | €0.3m | €0.4m | ▲ 15.8% |
| Cash at bank and in hand54/58 | €0.3m | €0.3m | €0.3m | €0.5m | €0.5m | €0.3m | €0.4m | €0.4m | ▲ 15.4% |
| Deferred charges and accrued income490/1 | - | - | - | €0.005m | €0.007m | €0.01m | €0.01m | €0.008m | ▼ 20.0% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.9m | €0.8m | €0.7m | €0.9m | €1.0m | €1.2m | €1.2m | €1.2m | ▼ 3.3% |
| Equity10/15 | €0.6m | €0.6m | €0.5m | €0.6m | €0.8m | €1.0m | €1.1m | €1.1m | ▼ 0.9% |
| Contributions10/11 | €0.006m | €0.006m | - | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Reserves13 | €0.5m | €0.6m | €0.5m | €0.6m | €0.8m | €1.0m | €1.1m | €1.1m | ▼ 0.9% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Distributable reserves133 | - | - | - | €0.6m | €0.8m | €1.0m | €1.1m | €1.1m | ▼ 0.9% |
| Provisions and deferred taxes16 | €0.003m | €0.001m | - | - | - | - | - | - | - |
| Amounts payable17/49 | €0.3m | €0.2m | €0.2m | €0.3m | €0.1m | €0.1m | €0.1m | €0.09m | ▼ 24.7% |
| Amounts payable after more than one year17 | €0.2m | €0.1m | €0.08m | €0.02m | - | - | - | - | - |
| Financial debts170/4 | - | - | - | €0.02m | - | - | - | - | - |
| Amounts payable within one year42/48 | €0.1m | €0.08m | €0.1m | €0.2m | €0.1m | €0.1m | €0.1m | €0.09m | ▼ 24.8% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.06m | €0.02m | - | - | - | - |
| Trade debts44 | €0.01m | €274 | €0.005m | €0.01m | €0.004m | €0.02m | €0.002m | €0.06m | ▲ 23× |
| Suppliers440/4 | - | - | - | €0.01m | €0.004m | €0.02m | €0.002m | €0.06m | ▲ 23× |
| Taxes, remuneration and social security45 | - | - | - | €0.08m | €0.1m | €0.1m | €0.1m | €0.03m | ▼ 71.3% |
| Taxes450/3 | - | - | - | €0.08m | €0.1m | €0.1m | €0.1m | €0.03m | ▼ 71.3% |
| Other amounts payable47/48 | - | - | - | €0.08m | - | - | €0.001m | €0.001m | ▲ 10.7% |
| Accrued charges and deferred income492/3 | - | - | - | - | - | - | €402 | €420 | ▲ 4.4% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €266,307 | €72,447 | €34,346 | €179,511 | €206,384 | €243,759 | €336,136 | €281,753 | ▼ 16.2% |
| + Depreciation and write-downs630 | €86,246 | €86,485 | €86,241 | €70,145 | €52,456 | €31,662 | €46,366 | €49,287 | ▲ 6.3% |
| Operating cash flow (approximation) | €352,553 | €158,932 | €120,587 | €249,656 | €258,840 | €275,421 | €382,502 | €331,040 | ▼ 13.5% |
| Investment in fixed assets (approximation) | - | -€2,398 | -€4,800 | -€1,455 | -€8,739 | -€128,181 | -€11,916 | -€13,914 | ▼ 16.8% |
| Change in cash | - | -€25,877 | €15,837 | €166,957 | €20,089 | -€211,477 | €110,810 | €57,489 | ▼ 48.1% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 17,811 companies had the same profile as DRS. EVERS - VANDERSCHOOT has now. Two years later, 96.5% were still going and 0.3% had gone bankrupt.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
96.5%
was still going
3.1%
stopped otherwise
0.3%
went bankrupt
That fits the bankruptcy probability of DRS. EVERS - VANDERSCHOOT itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for DRS. EVERS - VANDERSCHOOT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 18 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 27-07-2026 | 2026-00335952 | |
| 31-12-2024 | micro format | 30-07-2025 | 2025-00332712 | |
| 31-12-2023 | micro format | 28-06-2024 | 2024-00178708 | |
| 31-12-2022 | micro format | 30-08-2023 | 2023-00380812 | |
| 31-12-2021 | micro format | 11-07-2022 | 2022-20169912 | |
| 31-12-2020 | micro format | 22-07-2021 | 2021-38300030 | |
| 31-12-2019 | micro format | 13-07-2020 | 2020-29200047 | |
| 31-12-2018 | micro format | 10-07-2019 | 2019-31000114 | |
| 31-12-2017 | micro format | 23-07-2018 | 2018-36600291 | |
| 31-12-2016 | micro format | 11-07-2017 | 2017-30100358 |
Board & ownership
Directors
Directors
2 directors, last change in 2023
EVERS Stefan Irma Emmanuel Marie Joseph
Current
Niet statutair arts bestuurder · in office according to the act of 30-08-2023 · earlier director, until 30-08-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 27-07-2026
VANDERSCHOOT Britt Lisbeth Freddy
Current
Niet statutair arts bestuurder · in office according to the act of 30-08-2023 · earlier director, until 30-08-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 27-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 30-08-2023Owners and capital
Shareholders
Stated in the act
act of 30-08-2023 ↗
- EVERS Stefan Irma Emmanuel Marie Joseph 75 shares
- VANDERSCHOOT Britt Lisbeth Freddy 25 shares
Capital transactions
Capital over time
- 30-08-2023 Converted to unavailable equity · €8,060
Mandate history
2 people, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| EVERS Stefan Irma Emmanuel Marie Joseph |
|
| VANDERSCHOOT Britt Lisbeth Freddy |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Met of zonder beperking van duur, 1”
Articles of association, deed of 30-08-2023 (in Dutch)
Network & group
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
27-07
micro format · 4 days before the deadline
2025
30-07
micro format · 1 day before the deadline
2024
31-12
Financial
Highest result from 2018 to 2025net €336,136 ▲37.9%
The net result of €336,136 is the highest of those years.
28-06
micro format · 33 days before the deadline
2023
31-12
Financial
Equity above €1mequity €1.0m ▲23.3%
With a profit in every financial year since 2018, equity grows to €1.0m.
30-08
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointmentsResignations: EVERS Stefan Irma Emmanuel Marie Joseph (director) and VANDERSCHOOT Britt Lisbeth Freddy (director) · Reappointments: EVERS Stefan Irma Emmanuel Marie Joseph (niet statutair arts bestuurder) and VANDERSCHOOT Britt Lisbeth Freddy (niet statutair arts bestuurder) · Shareholding20 points ▸
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments
Resignations: EVERS Stefan Irma Emmanuel Marie Joseph (director) and VANDERSCHOOT Britt Lisbeth Freddy (director) · Reappointments: EVERS Stefan Irma Emmanuel Marie Joseph (niet statutair arts bestuurder) and VANDERSCHOOT Britt Lisbeth Freddy (niet statutair arts bestuurder) · Shareholding20 points ▸
- General meeting, 28-08-2023
- EVERS Stefan Irma Emmanuel Marie Joseph holds 75 shares
- VANDERSCHOOT Britt Lisbeth Freddy holds 25 shares
- Capital, mentioned 2 times in the deed
- Board composition, EVERS Stefan Irma Emmanuel Marie Joseph (director)
- Board composition, VANDERSCHOOT Britt Lisbeth Freddy (director)
- Incorporation, 02-05-2007
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “opheffing, statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Other provision, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Director resignation, EVERS Stefan Irma Emmanuel Marie Joseph (director)
- The act holds 8 more points.
30-08
micro format · 30 days late
2022
31-12
Financial
Liquidity more than doubledcurrent ratio 6.84
The current ratio rises from 3.26 to 6.84. Short-term debt falls from €233,592 to €129,393.
11-07
micro format · 20 days before the deadline
2021
22-07
micro format · 9 days before the deadline
2020
31-12
Financial
Weakest financial yearnet €34,346 ▼52.6%
The net result drops to €34,346, the lowest from 2018 to 2025. It recovers the following year.
13-07
micro format · 18 days before the deadline
Show earlier events
2019
10-07
micro format · 21 days before the deadline
2018
23-07
micro format · 8 days before the deadline
2017
11-07
micro format · 20 days before the deadline
2007
25-05
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
DRS. EVERS - VANDERSCHOOT in Dutch
Enterprise number
0889.482.377
LEI code
6994007LE09EJITB9496
live in the LEI register
Legal form
Private limited company
Status
Active, normale toestand
Founded
16-05-2007
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 30-08-2023 (in Dutch)Name clauseThe company operates under this name according to its articles.
Drs. Evers - Vanderschoot
deed of 30-08-2023 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest, Provinciale Raad van de Orde der Artsen en bijlagen Belgisch Staatsblad”
deed of 30-08-2023 (in Dutch)Registered office and establishments
Registered office
Stationsstraat 15, 3570 Alken, Belgium
Establishment unit
DRS. EVERS - VANDERSCHOOT, Stationsstraat 15, 3570 Alken since 16-05-2007 · unit number 2.302.353.792
Activities
NACEBEL 202586220
Specialist medical practice main activity
Codes under NACEBEL 2008
86220
Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 30-08-2023 (in Dutch)
“De uitoefening van de geneeskunde, in het bijzonder de algemene geneeskunde of de anesthesie en algologie (pijntherapie), met inachtname van…”
8 activities
- De uitoefening van de geneeskunde, in het bijzonder de algemene geneeskunde of de anesthesie en algologie (pijntherapie), met inachtname van de regels van de geneeskundige plichtenleer.
- De praktijk van arts wordt uitgeoefend door de arts onder zijn specifieke beroepsaansprakelijkheid en de bijkomende aansprakelijkheid van de vennootschap, maar in naam en voor rekening van de vennootschap.
- De activiteit omvat impliciet de inning van de erelonen door en voor de vennootschap en eventueel de betalingen aan de arts van een vergoeding in verhouding tot de prestaties die hij voor rekening van de vennootschap gepresteerd heeft.
- Het ter beschikking stellen van alle nodige middelen aan de arts.
- Het inrichten van algemene diensten nuttig of nodig voor de uitoefening van voornoemde activiteiten.
- Het verwerven en/of huren van alle medische apparatuur en begeleidende accommodaties voor de praktijk van de arts.
- Het optimaal beheer van de reserves als een ‘voorzichtig en redelijk persoon’; hiertoe mag de vennootschap onder meer alle roerende en onroerende activiteiten ontplooien die zij nodig of nuttig acht om de reserves rechtstreeks of onrechtstreeks veilig te stellen.
- De mogelijkheid scheppen om de arts toe te laten zich verder te bekwamen teneinde in zijn discipline aan de spits van de evolutie te blijven.
Invoicing and payment
VAT number
BE 0889.482.377
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Sites & property
Location
Buildings and parcels at the address
Ground area
3,756 m²
Building footprint
274 m²
Building volume
1,754 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 73302F0430/00N000 | Flanders | 3,756 m² | 1 · 274 m² | 11.4 m · 2 |